Lck inhibitor II

Lck inhibitor II is a cell-permeable, trisubstituted pyrimidine compound that potently and selectively inhibits lymphocyte-specific kinase (Lck) by targeting its ATP-binding site. This inhibitor is a valuable research tool for studying T-cell receptor signaling and has been utilized in both in vitro and in vivo models of T-cell activation and autoimmune disease research.